A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei-Reference-Cited by-同舟云学术

A Proposal for Modification of the PSOGI Classification According to the Ki-67 Proliferation Index in Pseudomyxoma Peritonei

Published:2021-07-02 Issue:1 Volume:29 Page:126-136
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Arjona-Sánchez Álvaro,Martínez-López Ana,Valenzuela-Molina Francisca,Rufián-Andújar Blanca,Rufián-Peña Sebastián,Casado-Adam Ángela,Sánchez-Hidalgo Juan Manuel,Rodríguez-Ortiz Lidia,Medina-Fernández Francisco Javier,Díaz-López Cesar,Granados-Rodríguez Melissa,Ortega-Salas Rosa,Castaño Justo P.,Tena-Sempere Manuel,Briceño-Delgado Javier,Romero-Ruíz Antonio

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-10372-9.pdf

Reference22 articles.

1. Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;33:511–9.

2. Govaerts K, Lurvink RJ, De Hingh IHJT, et al. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47(1):S11-35.

3. Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process. Am J Surg Pathol. 2016;40:14–26.

4. Rufian-Andujar B, Valenzuela-Molina F, Rufian-Peña S, et al. From the Ronnett to the PSOGI classification system for pseudomyxoma peritonei: a validation study. Ann Surg Oncol. 2021;28:2819–27.

5. Lund-Andersen C, Torgunrud A, Fleten KG, Flatmark K. Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review. J Gastrointest Oncol. 2021;12(Suppl 1):S191–203.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei;Biological Procedures Online;2024-05-15

2. Ovarian Causes of Pseudomyxoma Peritonei (PMP)—A Literature Review;Cancers;2024-04-09

3. Breaking the mucin barrier: a new affinity chromatography-mass spectrometry approach to unveil potential cell markers and pathways altered in Pseudomyxoma peritonei;2024-02-15

4. Surgical treatment of pseudomyxoma peritonei—Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy;Die Chirurgie;2023-08-14

5. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification;European Journal of Surgical Oncology;2023-08